Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)
Volume 96 | IMPE2023

IMPE 2023

Buenos Aires, Argentina
04 Mar 2023 - 07 Mar 2023

Card image cap
11th International Meeting of Pediatric Endocrinology (IMPE 2023). 4 -7 March 2023 - Buenos Aires, Argentina.

Free Communications

Diabetes and Insulin 1

impe0096fc11.1 | Diabetes and Insulin 1 | IMPE2023

Adolescents with type 2 diabetes experience significant diabetes-specific distress, poor emotional wellbeing and have unmet needs hindering optimal diabetes care

Spajic Dana , Subramani Gitanjali , Curran Jacqueline , Speight Jane , Shah Mark , James Radhika , Thus Maree , Pena Alexia

Introduction: Type 2 diabetes (T2D) is increasing among adolescents and is associated with suboptimal mental health. Diabetes-specific distress (DD) is common in adolescents with Type 1 diabetes but there is limited data in adolescents with T2D. Additionally, data in relation to how clinicians can better support the emotional wellbeing and engage adolescents with T2D is limited to Indigenous adolescents.Aims: To evaluate...

impe0096fc11.2 | Diabetes and Insulin 1 | IMPE2023

RIAO as an early biomarker of β-cell failure and predictor biomarker of metabolic syndrome

Altamirano-Bustamante Nelly , Belén Mosquera-Andrade María , Castillo Monica , Angel Blanco Miguel , Gonzàlez Alejandro , Revilla-Monsalve Cristina , Garrido Eulalia , Calzada-León Raul , M Altamirano Bustamante Myriam

Objective: Identify the factors association with the serum level of RIAO (real IAPP amyloid oligomers) <3.02 μg/ml at the diagnosis of the DM2 as a predictor of development of chronic complications in children and adolescents.Type of study: Historical cohort, observational, longitudinal, futurology, comparative,Materials and methods: The DM2 patients with determinations of RI...

impe0096fc11.3 | Diabetes and Insulin 1 | IMPE2023

Metformin added to intensive insulin therapy improves Neuregulin-4 level and subclinical atherosclerosis in youth with type 1 diabetes

Elbarbary Nancy , Abdel Rahman Ismail Eman , Atef Mohammed

Background: Neuregulin-4 (Nrg4), a recently identified adipokine, has been found in multiple organs, in particular brown adipose tissue. Lower Nrg4 levels have been associated with obesity, insulin resistance, impaired glucose tolerance and type 2 diabetes mellitus (T2DM). Metformin is widely utilized for treatment of T2DM due to its ability to improve glycemic control. It has shown some potential in preclinical studies to improve diabetic nephropathy, decreas...

impe0096fc11.4 | Diabetes and Insulin 1 | IMPE2023

Meal-induced activation of inflammatory pathways in youth with monogenic diabetes revealed by transcriptome analysis

Schwitzgebel Valerie , Stankute Ingrida , Howald Cedric , Blouin Jean-Louis , Verkauskiene Rasa , Xenarios Ioannis

Introduction: Diabetes represents a heterogeneous group of metabolic disorders, and monogenic diabetes is thought to affect 1- 5% of the pediatric diabetes population. Monogenic diabetes, typically presenting without autoimmune antibodies, causes neonatal diabetes, maturity-onset diabetes of the young (MODY), and syndromic diabetes. The study aimed to gain insight into the gene regulation pathways altered in MODY diabetes following a meal.<p class="abstext...